Lixa
2 known investors
Lixa develops NeoX, an antimicrobial technology targeting antibiotic-resistant bacteria and biofilm fouling across pharmaceutical, industrial, food, and agricultural sectors. The company addresses antimicrobial resistance through a single mechanism that operates across multiple markets with multiple licensing pathways.
Investors · 2
Frequently asked questions
- What does Lixa do?
- Lixa develops NeoX, an antimicrobial technology targeting antibiotic-resistant bacteria and biofilm fouling across pharmaceutical, industrial, food, and agricultural sectors. The company addresses antimicrobial resistance through a single mechanism that operates across multiple markets with multiple licensing pathways.
- Who are Lixa's investors?
- Lixa's investors include CERI, Melt Ventures.